When this outward potassium current is delayed, the recovery of the ventricular muscle is slowed, stretching the interval on the ECG and creating a vulnerable window where early afterdepolarizations can trigger dangerous arrhythmias. Prolonged QT interval on an electrocardiogram (ECG) represents a delayed ventricular repolarization, a physiological event that can evolve into a critical cardiac arrhythmia known as Torsades de Pointes.
Common Drugs Known to Prolong the QT Interval
The clinical significance of this interval is magnified when medications, prescribed to treat diverse conditions, inadvertently interfere with the heart's electrical stability. Some drugs possess a well-documented, high-risk potential to significantly prolong the QT interval, often requiring strict adherence to specific dosing protocols or contraindications.
These prolonged QT drugs require careful scrutiny because they can disrupt the delicate balance of ionic currents across cardiac cell membranes, transforming a standard treatment into a potential cardiac hazard. Some macrolide and fluoroquinolone antibiotics, including Azithromycin and Levofloxacin, particularly in patients with underlying cardiac conditions.
Common Drugs Known to Prolong the QT Interval
Furthermore, patient-specific variables such as age, genetic polymorphisms affecting ion channel function, and the presence of chronic diseases like heart failure or diabetes create a unique susceptibility profile for every individual. Drugs that prolong the QT interval typically function by blocking the rapid component of the delayed rectifier potassium current (IKr), which is primarily responsible for repolarization.
More About Prolonged qt drugs
Looking at Prolonged qt drugs from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Prolonged qt drugs can make the topic easier to follow by connecting earlier points with a few simple takeaways.
